Award of Merit Manufacturing: TEVA Biologics Manufacturing Facility | 2018-10-16 | Engineering News-Record
Patients Eagerly Awaited a Generic Drug. Then They Saw the Price. - The New York Times
Why You Should Still Buy Teva (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries 6-K (Current Report of Foreign Issuer) - TEVA PHARMACEUTICAL INDUSTRIES LTD - 6-K - September 09, 2016
Anything but Generic: A map for Selling to Teva Pharmaceuticals
Teva Pharmaceutical Industries Ltd. - In 2020, we've kept medicines moving. During the COVID-19 pandemic, our manufacturing, distribution and R&D sites remained open to continue supplying quality, affordable medicines to the nearly